| NAALAD2 |
Homo sapiens |
|
NAALAD2 is differentially expressed in 65 experiments [60 up/58 dn]: 17 organism parts: tonsil [0 up/2 dn], cerebellum [0 up/1 dn], ...; 13 disease states: normal [3 up/2 dn], malignant melanoma [0 up/1 dn], ...; 19 cell types, 15 cell lines, 8 compound treatments and 14 other conditions. |
| NAALAD2 |
|
C35C5.11 (Caenorhabditis elegans)
R57.1 (Caenorhabditis elegans)
VPS70 (Saccharomyces cerevisiae)
Naalad2 (Mus musculus)
zgc:56429 (Danio rerio)
(Compare orthologs)
|
|
|
| Peptidase M28, Protease-associated PA, Transferrin receptor-like, dimerisation |
|
|
| carboxypeptidase activity, dipeptidase activity, dipeptidyl-peptidase activity, metallopeptidase activity, peptidase activity |
|
|
|
Q4G181
Q4KKV4
Q8IUX3
Q9Y3Q0
|
|
|
|
ENSG00000077616
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
FLAP
|
Compound treatment |
|
|
Stromal cell
|
Cell type |
|
|
None
|
Compound treatment |
|
|
Caco-2
|
Cell line |
|
|
MK886
|
Compound treatment |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
Tonsil
|
Organism part |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Cystic change
|
Histology |
|
|
HNRPA2B
|
Compound treatment |
|
|
Cerebellum
|
Organism part |
|
|
White blood cells
|
Organism part |
|
|
Caudate nucleus
|
Organism part |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
Johnsen score count 3.2: Serto...
|
Histology |
|
|
Johnsen score count 5: no sper...
|
Histology |
|
|
Malignant melanoma
|
Disease state |
|
|
Mesenchymal stem cell
|
Cell type |
|
|
Tumor
|
Organism part |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
T84
|
Cell line |
|
|
HaCaT
|
Cell line |
|
|
Kidney
|
Organism part |
|
|
Peripheral blood
|
Organism part |
|
|
Johnsen score count 10: full s...
|
Histology |
|
|
CD34+
|
Cell type |
|
|
SKMEL5
|
Cell line |
|
|
Endothelial cell
|
Cell type |
|
|
Fibroblast
|
Cell type |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
Clear cell sarcoma of the kidn...
|
Disease state |
|
|
Hematopoietic stem cell
|
Cell type |
|
|
Adipose tissue-derived stem ce...
|
Cell type |
|
|
Epilepsy
|
Disease state |
|
|
Affymetrix Labeling
|
Protocol type |
|
|
Cancer18
|
Replicate |
|
|
Thymus
|
Organism part |
|
|
Lung
|
Organism part |
|
|
MCF-7
|
Cell line |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
Smooth muscle
|
Organism part |
|
|
A. fumigatus condia in media
|
Growth condition |
|
|
Pancreatic cancer
|
Disease state |
|
|
Lymph node
|
Organism part |
|
|
MCF10A
|
Cell line |
|
|
Germ cell
|
Cell type |
|
|
Native skin
|
Cell type |
|
|
Metastatic
|
Disease staging |
|
|
Grade III
|
Tumor grading |
|
|
Empty vector
|
Gene modification |
|
|
Fetal bovine serum in media
|
Growth condition |
|
|
Total_RNA
|
Material type |
|
|
Polysome-associated RNA
|
Material type |
|
|
Enzo Labeling
|
Protocol type |
|
|
Psoriatic lesional biopsy
|
Clinical info |
|
|
Uninvolved biopsy
|
Clinical info |
|
|
HPL1
|
Cell line |
|
|
Beas2B
|
Cell line |
|
|
Methotrexate
|
Compound treatment |
|
|
Johnsen score count 8: hypospe...
|
Histology |
|
|
Multipotent adult progenitor c...
|
Cell type |
|
|
Vulvar intraepithelial neoplas...
|
Disease state |
|
|
Primary lymphatic endothelial ...
|
Cell type |
|
|
5-aza-2'-deoxycytidine + trich...
|
Compound treatment |
|
|
HL-60
|
Cell line |
|
|
Infrared light
|
Light |
|
|
Oligodendroglioma
|
Disease state |
|
|
YCC16
|
Cell line |
|
|
Pituitary
|
Organism part |
|
|
Serum starvation + thymidine b...
|
Growth condition |
|
|
BDCA1+ dendritic cell
|
Cell type |
|
|
Treated malaria, natural infec...
|
Disease state |
|
|
Chondrocyte
|
Cell type |
|
|
Epithelial cell
|
Cell type |
|
|
Astrocyte
|
Cell type |
|
|
HeLa
|
Cell line |
|
|
Undifferentiated
|
Phenotype |
|
|
Differentiated
|
Phenotype |
|
|
Phorbol 12-myristate 13-acetat...
|
Compound treatment |
|
|
Experimental malaria-infected
|
Disease state |
|
|
Keratinocyte
|
Cell type |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
U937
|
Cell line |
|
|
X-linked chronic granulomatous
|
Disease state |
|
|
Leydig cell
|
Cell type |
|
|
Pancreatic ductal adenocarcino...
|
Disease state |
|
|
Baseline uninfected
|
Disease state |
|
|
Trichostatin A
|
Compound treatment |
|
|
Dorsal root ganglion
|
Organism part |
|
|
SCH
|
Cell line |
|
|
Media only
|
Growth condition |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
STA ET2.1
|
Cell line |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Testis - seminiferous tubule
|
Organism part |
|
|
BCBL-1
|
Cell line |
|
|
Johnsen score count 7: many ea...
|
Histology |
|
|
IgV mutated
|
Genotype |
|
|
Estrogen receptor 1 negative; ...
|
Test result |
|
|
Serum starvation synchronizati...
|
Growth condition |
|
|
Pons
|
Organism part |
|
|
|
|
|
Processing time: 0.113 secs.